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Advisor: Joshua C. Brumberg, Ph.D. 
 
 The brain performs cognitive processes finely orchestrated by timely precise action of 
neurons. Neurons functioning at their highest standard communicate with each other through 
perfectly functioning synapses. Microglia, as part of the immune system assist synaptic 
processing and have the ability to affect cognition. Indeed, microglia play a role in cognition. To 
investigate the link between microglia and cognition we utilized lipopolysaccharide (LPS) to 
pharmacologically activate microglia. LPS, normally present in the environment on the wall of 
Gram-negative bacteria is a pharmacological agent used to cause microglia activation in mice. 
LPS is a typical model to study changes induced by microglia activation.  A systemic LPS 
inflammation was induced in C57BL/6 mice of either sex via a single intraperitoneal injection of 
low concentrations 0.5 mg/Kg LPS or 1mg/Kg LPS with 0.9% saline injection as a control and 
behavioral responses were evaluated with Ethovision XT. A modified version of the novel object 
paradigm helped us evaluate if the animal can discriminate the novel object based on texture. 
Although no significant difference was found in the mice’s ability to discriminate textures, other 
locomotion measures such as speed and total distance traveled revealed differences in the 
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mouse’s performance to differentiate a novel object. There was significant difference on both 
parameters due to the presence of the novel object although the LPS treatment condition did not 
impact this behavior.  The current study offers the instrumentation to test the effects of microglia 
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The role of microglia 
When we think about brain function, we often think about the circuits that work together 
in the brain and contribute to behavioral responses. Until recently we only thought about 
neurons. In fact, half of the brain cells are not neuronal cells. During the 19th Century, many 
scientists (e.g., Purkinje, Valentin and Henle among others) noticed that neurons were embedded 
into some sort of nerve connective tissue, a protein-fat based substance with insulating 
properties. It was Virchow, who named it “neuroglia” (Virchow, 1863). Virchow describes it as a 
substance of great softness which lies everywhere, conforming the continuous interstitial tissue 
which changes appearance from granular, striated to reticulate. He gave up on the preconception 
of his ancestors that it was connective tissue and saw it more like a cement that holds the nervous 
elements in place (Virchow, 1863).   
Golgi (1870) confirmed his previous observations of the interstitial tissue in the 
cerebellar structure with his recently discovered staining technique named “the black reaction”. 
Indeed, he was able to differentially stain glial cells from nerve cells or nerve fibers (Mazzarello 
& Haines, 2012).  
Neuroglia cells, were called arachnoid cells due to their similarity to a spider. They were 
also called Deiter’s corpuscles to honor the scientist who discovered them, and they were 
thought to be a support medium for the neurons. These cells serve as a facilitator of nerve 
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connectivity and at the same time act as insulator.  Due to their proximity to capillaries it was 
thought that they also served a protective/gatekeeper role (Ramon Cajal, 1899). 
Gierke (1886) further elaborated upon the term neuroglia after describing different types 
of neuroglial cells, both in the white and gray matter from diverse regions of the nervous system 
such as the brain and the spinal cord. In response to Jastrowitz and others, he proposed the 
existence of a space in between the nervous elements. This space was postulated to be filled with 
this supportive substance of the Central Nervous System (CNS). This was the same substance 
that others called connective tissue, or reticular connective tissue, due to its histological 
implication. Therefore, following Virchow’s opinion, he established that it must be called 
neuroglia, or simply glia (Chvatal & Verkhrastsky, 2018). 
Neuroglia comprises heterogeneous cellular groups proceeding from differentiation of 
two cells during development:  the neuroepithelial or mesodermal cells which renders two types 
of neuroglia within the CNS, macroglia and microglia. Macroglia have an ectodermal origin 
whereas microglia have a mesodermal origin. Furthermore, macroglia includes three types of 
cells; astrocytes, oligodendrocytes, and oligodendrocyte progenitor cells (NG2 glia). Neuroglia 
in the peripheral nervous system (PNS) includes Schwann cells and satellite glia among others. 
Figure (1) illustrates this classification. All have different morphology, and duties with one 
common objective: maintaining homeostasis of the nervous system (Verkhratsky & Butt, 2013).  
Communication among glia cells is essential for neural modulation. Within the 
microenvironment in the brain that is surrounding the neurons, microglia exchange signals with 
astrocytes to maintain homeostasis (Kaur & Eng-Ang, 2012). Additionally, microglia are part of 
a reciprocal modulation system for neural-microglia communication (Wang, et al., 2019). 
Microglia constantly survey and sculpt synapses, contributing to synapse elimination and 
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formation, as well as promoting functional synaptic maturation necessary for normal behavior 
(Chung, Welsh, Barres, & Stevens, 2015). Long lasting changes in spine dynamics were 
associated with persistent up-regulation of microglia in vivo (Kondo, Kohsaka, & Okabe, 2011) 
Astrocytes and microglia sustain active communication to regulate synapse functioning. In fact, 
astrocytes tag the less active synapses for elimination by microglia. Indeed, astrocytes bridges 
with associated microglia which work together to initiate synaptic pruning (Chung, Welsh, 
Barres, & Stevens, 2015). 
Different morphologies of microglia have been directly associated with their functional 
state. Figure (2) represents an interpretation of the microglia morphological changes as it 
increases its activity. According to its morphology microglia have been classified into three 
groups: the resting microglia, the surveilling and ramified microglia, and the activated microglia. 
First, the resting microglia possesses processes with many ramifications with a great number of 
small branches. These ramified processes are constantly surveying and dynamically monitoring 
their surroundings (Fontainhas, et al., 2011). Second, the surveilling and ramified microglia, 
which lose some of the most distal branches and adopt a spider-like shape, retaining only the 
primary ramification. Finally, there are the activated microglia and the phagocytic or amoeboid 
microglia that loses all the ramifications and acquire an amoeboid shape. (Verkhratsky & Butt, 
2013).  
It was Pio Del Rio-Hortega (1932) who published a complete chapter dedicated to 
Microglia in his seminal book: Cytology and Cellular Pathology of the Nervous System, edited 
by Wilder Penfield in 1932. His vast experience as a histologist was used to study glia and the 
brain. It was by working with neurosurgeons and pathologist that he obtained large amounts of 
brain tumor specimens for his studies. The neuro-embryological data provided results to unveil 
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the pathways of the medullary epithelium (Ramon y Cajal, 2016). In an effort to establish the 
degree of ramification of microglia, several methods have been utilized to classify microglia 
based on their morphology. The Sholl method differentiates amoeboid from ramified but lacks 
the ability to characterize microglia through intermediate stages. In vivo, microglial cells were 
quantified in the ischemic rat brain (Soltys, et al., 2005). The authors used a subjective cell 
classification system. Ramified cells (RM) were defined as small cells with round bodies and 
abundant branches of processes that are regularly distributed. Hypertrophic cells (HM) were 
shown to have irregular larger bodies with irregular thicker processes. Bushy cells (BM) had 
large bodies with numerous but scarcely ramified processes. Lastly, the amorphic cells (AM), 
which are characterized by having an amoeboid shaped body with few processes, or none at all. 
Other scientists, combined their classification with the ramification factor (FF), the measured 
solidity (IR) and a principal component analysis to establish a quantitative morphological 
assessment of microglia during activation (Soltys, et al 2005). 
The brain has a direct regulatory impact on the immune system 
Microglia are the main component of the immune system within the central nervous 
system, in charge of detecting invaders (Besedovsky & del Rey, 1983). Microglia are equipped 
with a wide arrange of receptors for surveillance. Microglia detect pathogens and endogenous 
substances through the Pattern-recognition receptors (PRRs) such as the Toll-like receptors 
(TLRs), and damage-associated molecular patterns (DAMPs), among others. Microglia intervene 
during inflammatory processes to reestablish homeostasis (Bellavance & Rivest, 2012). 
Dysregulated glial synapse elimination is common in several neuropshychiatric disorders such as 
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Parkinson’s disease,  Schizophrenia, Alzheimer’s disease (AD), Autism Spectrum Disorder 
(ASD), among others (Chung, Welsh, Barres, & Stevens, 2015). 
Parkinson’s disease (PD) is a chronic, neurodegenerative disease with one implicated 
pathogenic factor: inflammation. Chronic microglia inflammation was found in post-mortem 
brain of PD patients (Kannarkat, Boss, & Tansey, 2013). Additionally, the permeability of the 
brain blood barrier (BBB) can change due to inflammation, allowing an influx of adaptive 
immune cells from the periphery.  These are activated by the CNS resident inflamed microglia, 
propagating inflammation into other CNS regions that already contain the antigens. This chain of 
events induces a positive feedback which acts as a vicious cycle of neuronal injury that is 
considered a catalytic factor in the progression of PD (Tansey & Goldberg, 2009). 
Alzheimer’s disease (AD) is a pervasive disorder. It is one of the neurological disorders 
with highest incidence, in the United States, one in 10 people, age 65 and older are diagnosed 
with AD (Feigin, Nichols, & Vos, 2019). As this neurodegenerative disorder progresses, patients 
present problems with declarative memory, sense of orientation, and other cognitive deficits that 
affect decision making and judgement (Hong, Dissing-Olesen, & Stevens, 2016). Signals that 
usually promote clearance of invading pathogens have specific receptors which help the normal 
dendritic pruning process during development. In a healthy adult brain, these signals are 
downregulated, whereas in AD patients they are upregulated.  In the case of the latter, they are in 
localized areas such as the hippocampus (Stephan, et al., 2013). Observing microglia in healthy 
individuals helped researchers to identify important markers on microglia before, during and 
after the onset of AD (Hong, Dissing-Olesen, & Stevens, 2016). Further research is required to 
establish patterns to alert and stop this debilitating disease before major damage takes place. 
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Schizophrenia is one of the most debilitating psychiatric disorders. Genetic aberrations, 
prenatal infections and complications at birth are the main underlying causes of Schizophrenia, 
which manifests at a critical age during adolescence and early adulthood. (Cardon, Ron-Harel, 
Cohen, Lewitus, & Schwartz, 2010). Animal models for schizophrenia strongly correlate 
microglia activation in the pregnant mother with behavioral deficits in offspring (Patterson, 
2011). 
LPS possible alternative to induce an inflammatory process 
Inflammatory processes caused by Lipopolysaccharide (LPS) have been used to study 
microglia activation in lab animals (Sousa, et al., 2018). LPS is the major component of the outer 
membrane of Gram-negative bacteria (Zhao, et al., 2019). This immunostimulant is often used to 
cause inflammatory reactions in mice (Qin, Wu, & Block, 2007). LPS is a widely applied model 
to study neuroinflammatory processes in mice because is resembles neuroinflammatory 
processes that are common in several neuropshychiatric disorders. LPS used during the 
gestational period affects prunning in Autism Spectrum Disorder (ASD) such that male subjects 
presented behavior that resembles ASD (Fernandez de Cosio, Guzman, van der Veldt, & 
Luheshi, 2017).  A single intraperitoneal (IP) injection of LPS has been recognized to cause a 
strong immune response in normal mammalian cells both in mice and in humans (Sousa, et al., 
2018). Intraperitoneal injection of LPS (4 µg LPS/g body weight) versus PBS (saline) as vehicle 
control in 3 to 4 month old mice was used to study the diverse reaction to systemic inflammation 
. The analysis on the brain tissue was performed twenty four hours after the injection (Sousa, et 
al., 2018). A mice model of direct LPS intranigral injection helps in  understanding the 
mechanisms of action of innate immune cell’s receptors in response to inflammatory responses 
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caused by neurotoxicity (Herrera, Castano, A., & Machado, 2000). Inflammatory processes 
caused by bacterial infections that affect microglia are accompanied by cognitive deficits 
(Kondo, Kohsaka, & Okabe, 2011). Many researchers have used different methods of injection, 
and while some prefer to follow up on cognitive deficits caused by repeated injections (Barter., 
Kumar, & Rani, 2020), some used intraperitoneal, or even a direct intra-cerebro-ventricular 
(ICV) injection in areas of interest in the brain (Zhao, et al., 2019). Although IP injections often 
require a higher concentration to cause effects because LPS hardly gets to cross the brain blood 
barrier when applied in single doses, the IP injections are preferred over the ICV method due to 
fewer post-surgery complications. 
Vichaya (2018) attempted to establish a relationship between inflammation and 
depression. A single IP injection of 0.5 mg/Kg LPS was used to study a Ribonucleic Acid (RNA) 
sequence of parietal cortical tissue 24 hours after the injection. The analysis revealed that 128 
genes were significantly dysregulated in response to the LPS injection. They compared the 
behavioral results of a double injection of 0.33 mg/Kg a week apart from a second injection of 
1.0 mg/Kg LPS this second higher concentration was selected due to the blunt effect of chronic 
LPS applications. They reported that a sickness episode is common during the first 3-15 hours 
post injection. The episodes were described as loss of body weight due to decreased water and 
food consumption, and reduced locomotion. Furthermore, 24 hours post injection tests revealed 
depression-like behavior. Additionally, they reported that mice started recovery 36 hours to 72 
hours after the injection. They claim that the concentrations used in this study caused systemic 
inflammation without disruption of the brain blood barrier (Vichaya, et al., 2019).  
LPS-induced neuro-inflammation can cause cognitive deficits. I proposed to study the 
mouse’s ability to discriminate a novel object with a single application of LPS under two 
8 
 
concentrations LPS-1, which is 1.0 mg LPS per Kg of mass mouse weight and LPS-0.5, which is 
0.5 mg LPS per Kg of mass mouse weight. The behavioral test with the novel object is 
conducted approximately 72 hours post-injection. Ambulatory parameters such as speed and 
distance will reveal changes in their behavior as indirect measures of their interest to stop and 
examine the novel object. Individuals vary their reaction to environmental clues by gender. 
There is a gap in research methodologies that ignore gender when they either segregate one 
single gender or they group them as a unified group. My study will examine gender as a factor.  
How object recognition happens 
Rodents use their whiskers to scan their environment and gain spatial information and/or 
differentiate objects. The whisker’s related primary somatosensory cortex (wS1) known as the 
barrel cortex, connects with networks that process and integrate sensory, motor signals and 
receives top-down feedback, which combines sensorial perception with motor output on 
behavioral tasks such as learning and exploring (Petersen, 2019). The whisker-related primary 
somatosensory cortex (wS1) of mice and rats contain an arrangement of anatomically 
differentiated units of cells, where each unit or barrel represents one whisker on the contralateral 
mystacial pad. The signal passes via the brainstem and the thalamus before reaching the 
contralateral side of the somatosensory cortex wS1, where the latency from whisker deflection to 
depolarization of neurons in wS1, is approximately seven ms (Ferezou, et al., 2007) 
Whiskers positioning, shape and flexibility facilitate collection of information about the 
animal’s surroundings when they are exploring. This is an active process that initiates by a 
scanning movement of the whiskers back and forth at about 10 Hz (Lefort, Tomm, Sarria, & 
Petersen, 2008). Every single whisker on the snout is represented within Layer 4 of the 
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somatosensory cortex in a clearly defined area. In fact, that area forms a ring of cells – named a 
barrel, which covers somewhere from 100 µm to 400 µm in diameter. Moreover, the barrels are 
perpenticular to the pia, and the space surrounding them is called the septum (Woolsey & van 
der Loos, 1970). Because the barrel’s map has a bilateral arrangement constitent within one or 
several individuals of the same group, such as mice or rats, the barrels became a unique system 
to study with reproducible results. 
The whisker pad ultimately projects to the barrel cortex (wS1), which is organized in 
horizontal rows and vertical arcs. They are named as A, B, C, D and E on a dorsal-ventral axis. 
This rows contain numbers starting with one posteriorly and moving anteriorly. Rows A and B 
contain only four whiskers and rows C through E contain seven. This somatotopy is recapitulated 
at the level of the brainstem and thalamus prior to reaching the Layer 4 barrels in the primary 
somatosensory cortex (S1). Within S1, C2 for instance contains approximately 6,500 neurons, it 
is a barrel column representing the third row of whiskers and from the second whisker counting 
from the rear (Petersen, 2019).  
The somatosensory cortex has a layered arrangement (1-6), labeled from the pial surface 
to the white matter as layer (L) L1, L2, L3, L4, L5 and L6. Each layer has characteristic input 
and output connections among neurons (Markram, et al., 2004). The barrel cortex shows a 
vertical organization that receives thalamocortical input and transfers the signaling to 
supragranular and then on to infragranular layers (Feldmeyer, 2012). 
The neocortex is comprised of (70-80%) excitatory pyramidal neurons and (20-30%) of 
interneurons (Lefort, Tomm, Sarria, & Petersen, 2008), the majority of which are inhibitory.  
These inhibitory interneurons use the neurotransmitter, GABA (ɣ-amino-butyric acid), and 
although they vary greatly in their dendritic, somatic and axonal morphologies, they can be 
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characterized anatomically by their axonal arborization (with specialized action on different 
target neurons) and the lack of spines on their dentrites, so called smooth dendrites. A 
classification based on dendritic morphology as multipolar, bipolar or bitufted interneurons is not 
enough. The targeting axon categorize them by functionality whether they are axon-targeting, 
soma, or proximal dendrite. Furthermore, dendrite and tuft-targeting provides a more complete 
characterization. Another property for classification is their location: intralaminar-intracolumnar, 
intralaminar-intercolumnar or intralaminar-intercolumnar (Markram, et al., 2004). Some 
subtypes of these inhibitory interneurons serve important roles in cortical functions (Xu, Jeong, 
Tremblay, & Rudy, 2013)  
High order processes such as sensory perception take place in the neocortex by networks 
of excitatory neurons called pyramidal cells (PCs) from L2 and L3 that connect through a 
descending pathway to Layer 5 (Feldmeyer, 2012). Their cell bodies are located in Layers 2 and 
3, sending long-range axonal projections to other cortical locations, for instance, they first go to 
the secondary whisker somatosensory cortex (wS2),  then move to the primary and secondary 
whisker motor cortex (wM1/2) before finally surrounding the barrel field towards the perirhinal 
temporal association cortex and striatum (Yamashita, et al. 2018). Superficial and deep layers are 
connected through reciprocal pathways. Neurons in L4 of wS2 connect to wS1 to send 
information about orientation of the stimulus to modulate tactile processing with somatotopic 
alignment that allows for the preservation of information about the stimulus in a dynamic 
feedforward and feedback system with reciprocal connections between wS1 and wS2 on L4 for 




Recent optogenetic studies revealed how sensory coding, more specifically fine tune of 
perception of space, happens when communication between Layers 2/3 and layer-5 takes place 
when not interrupted by somatostating (SOM) interneurons (Pluta, Telian, Naka, & Adesnik, 
2019). 
The brain homeostasis changes influenced by several factors such as stress or 
inflammation (Paolicelli & Ferreti, 2011). Given that microglia play a role in responding to 
injuries and infections, it is not suprising that microglia have an active role in synaptic activity 
(Ueno, et al., 2013). Biochemical quantification of the Extracellular Matrix (ECM) and the ECM 
modulating enzimes showing decreased levels of key components of the specialized network 
called perineuronal net (PNN) lead researchers to hypothesize that the ECM plays a role on 
altered states of cognition after microglia activation, and that it is done through the stabilization 
of GABAergic interneurons by its surrounding PNN (Tajerian, et al., 2018). The activation of 
microglia and stabilization of the Gabaergic interneurons during inflammatory processes can 
produce changes on cognition that vary with the severity of the inflammation. 
Behavior Studies as a measure of cognition 
 Wu et al. (2012) developed a texture discrimination method to evaluate the mouse’s 
sensibility to detect gradient of textures such as a smooth surface or a corrugated surface. They 
demonstrated that C57BL/6 mice as young as two-months old and as old as 6-months old are 
able to encode information such as texture, shape or size by using their mystacial vibrissae with 
tactile exploration (Wu, Ioffe, Iverson, Boon, & Dyck, 2013) Figure 3 illustrates the Novel 
Object paradigm utilized. 
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The Open Field Test (OFT) is a modification of the Open Field Maze (OFM) 
(Seibenhener & Wooten, 2015) used to evaluate anxiety on subjects which are also evaluated on 
other procedures such as the novel object paradigm (NOP). The OFT defines a ratio of the 
permanence of the subject in an open central zone related to the total arena. Subjects that are 
more anxious tend to remain on the periphery longer. The current study uses a similar OFT task 






A total of 24 C57BL/6 mice (age = P60) were purchased from Charles River 
Laboratories. Mice were housed in pairs, 12-h light/dark cycle and room temperature of 22±4oC. 
Water and Food were available ad libitum.  They were allowed to acclimate with one partner to 
one cage for 8 days prior to the experiment. All animal procedures are in accordance with NIH 
guidelines for the ethical use of animals in biomedical research and have been approved by the 
Institutional Animal Care and Use Committee of Queens College, CUNY (Protocol# 100). Equal 
number of mice from each gender were randomly assigned to the treatments. The subjects were 
identified, weighted, and marked.  Five days of daily checkup and weight recordings were used 
to evaluate their condition and readiness for the experiment. 
Treatments to use 
There was a set of 4 cohorts. Each cohort was divided into three groups and randomly 
assigned to three treatments: LPS-1, LPS-0.5 and Saline. The treatments were administered using 
a 1ml #30G syringe by an intraperitoneal (IP) injection of injectable Lipopolysaccharide 
(LPS)solutions to reach 1mg of LPS per Kg of mice for the LPS-1 and 0.5mg of (LPS) per Kg of 
mice on the LPS-0.5 and no LPS, only saline solution for the control See Table 1. The 
Intraperitoneal (IP) procedure from the UBC Animal Care guidelines1 was followed. Note that 
the amount of solution to inject should be less than 10 ml/Kg. Example in a 25 gr mouse, the 
maximum volume to inject is 0.25 ml. 
 
                                                          
1 Andrews, Kris. UBC Animal Care Guidelines May 2014. www.ccac.ca 
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Solutions to prepare 
Two solutions are needed. First, a 0.9% Saline solution and the LPS-stock solution. The 
0.9% Saline Solution, was prepared by dissolving 9 gr of NaCl in 1000 ml of dH2O.  Second, the 
LPS-stock solution corresponds to a concentration of 5%. Weigh 5mg of LPS powder and 
dissolve in 100 ml of 0.010M PBS, calibrate its pH to 7.4. Keep the remainder of the solution in 
the fridge. Warm it up to room temperature for 20 min when you are ready to use.  
Behavioral Procedures 
 According to the behavioral procedures from the Noldus Manual (Spink, Tegelenbosch, 
Buma, & Noldus, 2019).  
Novel object paradigm (NOP) 
The NOP was applied before (figure 3A) and two days after (figure 3B) the I.P. injection. 
The novel object was in a counterbalanced position in between trials. The arena consists of a 
white plastic container that has the following dimensions: 34 cm x 29 cm (width: length) (figure 
3D). The objects were two laser printed red pillar cylinders of 5 cm in diameter and 2 inches 
high. Some had a smooth surface while others had a corrugated texture with vertical indentations 
of 3mm in depth around the exterior surface. After habituation, the subjects are ready for the 





The habituation task takes place in the arena without objects, the mouse was left to 
explore for 20 minutes with the light on and the camera off. The subject under habituation must 
be alone on the arena and on the testing table.  
Acquiring data protocol 
A typical novel object test consists of three phases: Acclimation, Pretest (t1) and Test 
(t2). The videos were recorded with a Basler high-definition camera which is set up through 
Ethovision for behavioral studies. 
Acclimation Phase  
Acclimation consisted of a video recording of 10 min in the arena without objects. The 
arena is a white plastic container of a rectangular shape. It had the following dimensions: 34 cm 
x 29 cm (width:length). After the acclimation period, the subject was placed into their home cage 
for 15 min with its partner until behavioral testing commenced. The Video Tracking used Noldus 
Ethovision XT-15. The total distance (cm) the subject ambulated both in the center and in the 
periphery was collected. In the data profile measurements were set to collect the time of 
permanence using as a reference the center point of the mouse. 
Open Field Test (OFT) 
The acclimation videos are used to analyze the OFT. Two zones were identified, the 
center and the periphery. The periphery was defined as a corridor 6 cm wide around the center of 
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the arena. The OFT parameter is calculated as the ratio between the time spend in the center to 
the time spent in the arena. 
Phase t1 
After acclimation, the animal was put back in the arena in which two identical objects 
had been placed, such as two objects of the same texture e.g.; smooth:smooth. The subject was 
put at a midway position between the objects, such that its nose points towards the wall. The 
subject was videotaped for 20 min, it was then taken out of the arena and put back in its home 
cage for 15min. A Trial Control Settings profile for this phase was determined and then this 
profile was assigned to the trials of type t1. In the data profile set measurements to be collected 
on the nose point of the mouse. 
Phase t2  
One of the objects in the open field was subsequently replaced with a novel object which 
in our case had a different texture. The subject was placed back in the arena as before. 
Videotaping lasts 20 minutes. Once again, a Trial Control Settings profile for this phase was 
defined and was assigned to all the trials of type t2.  
Video tracking is set for the first 10 minutes on both t1 and t2, under both conditions, 
before and after the injections. We decided to use the first 10 minutes of recording because we 
observed diminishing activity as time elapsed. Although the original Noldus NOP suggests only 
five minutes of video-tracking, we saw the need to extend it to 10 to improve accuracy of 




Behavior Data before and after the injections, only during t2 
 Cumulative Duration which is the amount of time (s) the subject spends within 2 cm 
outside of the perimeter of the object and near the object considering the nose-point. Two 
centimeters allows for contact of the object by the whiskers. The time that the mouse is on top of 
the object considering the center point is excluded because it is not considered exploratory. 
Locomotion Data for t1 and t2 only after the IP injection 
 The total ambulatory time, defined as Distance (cm) that is the total distance the mouse 
ambulated across the arena and the Speed (cm/s).  
Exclusion criteria and outliers 
Mice that didn’t move at all during acclimation qualify for exclusion. None of the 
subjects were excluded. In the case that extreme outliers are found, square root transformation of 
all the data in its category will be applied to evaluate statistically, then untransformed to report 
results (Field, Miles, & Field, 2012) 
Novel Object Settings: 
I used a “custom template” this opens the experiment without the data, so you can create 
a different experiment every time with the same settings. The Data Profile needs to follow a 
defined set of instructions on Ethovision to collect the desired data. For example, the total 
ambulatory time, the speed, and the cumulative duration inspecting the objects. The video 
sample rate used was: 25 frames per second with white light. The room temperature and level of 
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noise were kept constant. Videotaping sessions last 20 min and video tracking was performed on 
the first 10 minutes of the collected video. Setting up the data profile on the video track allowed 
for collection of the locomotion data such as the speed (cm/s) and the distance ran during the 10 
min of video track. Additionally, we quantified the amount of time (s) named as the cumulative 
duration the animal spends inspecting or exploring the objects within 2 cm of the objects and 
excluding the amount of time on top of the objects once it is not considered exploratory. This is 
based on a nose point (Wu, Ioffe, Iverson, Boon, & Dyck, 2013). 
The videos are saved for back-up purposes and the statistical analysis data is exported 
into Excel. The cage is washed after each subject to avoid odor interferences. Counterbalance of 
the position of the novel object was applied to avoid learning effect. 
 
ANALYSIS 
 All the statistical analysis and figures were produced with “R” version 3.6.1. 
Some figures are obtained using Microsoft Excel. Alpha value used was 0.05. 
Weight Follow up and Change on Weight 
Statistical model: 3 x 2 mixed design ANOVA will allow us to establish differences between the 
changes on weight. 
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OFT – Acclimation 
 The Open Field Test (OFT) was a parameter used to measure the degree of 
readiness for the experiment. The OFT test can indicate if the mouse presents excessive anxiety 
(Seibenhener & Wooten, 2015). It was conducted before and after the administration of the 
injection. The first, “before” indicates the readiness for the experiment, and the second “after” 
indicates if its state was not altered due to the application of the injection therefore their 
readiness for data acquisition. 
Two zones were defined: center and periphery. Arena dimensions are 29 x 34 cm. The 
center = 17 cm x 22 cm, and the periphery is a 6 cm wide corridor around the center. 
The Statistical model applied was: the t-test dependent measure because we had one 
group of subjects, with two conditions before and after injection. The Dependent Variable (DV) 
is the Discriminatory ratio of the open field test called OFT. 
OFT = time in center / (time in center + periphery) 
Two sets of Statistical analysis 
The statistical analysis on Locomotion and the discriminatory score of cumulative 
duration (DSCD) was set under two situations: first, we need to use the data only after the 
injection to establish differences due to the presence of the novel object (t1:t2). Second, we use 
the data only on t2 to establish differences about Treatment time, with its two parameters, before 




Locomotion – Speed and Distance 
Statistical model: 3 x 2 mixed design ANOVA allowed us to establish differences 
between subjects exposed to two different conditions: tTime, with both conditions: t1 and t2. The 
between part of the analysis includes: Treatment and Gender. The second analysis the within-
subjects analysis in which the variable tTime switches with the variable Treatment time. 
The two dependent variables: Distance (cm) and Speed (cm/s) will be evaluated 
independently. 
Behavior – Analysis  
This analysis was performed on the Discriminatory Score on Cumulative Duration 
(DSCD). The DSCD was computed by dividing the amount of time the mouse spends inspecting 
the novel object divided by the amount of time the animal inspects both the novel and the 
familiar objects. By using data after the injection, we compare t1 and t2. Additionally, the 
analysis is performed using the data on t2 and comparing treatment time (before and after). The 
Statistical model to use is a 3 x 2 mixed ANOVA to look for possible differences due to 
Treatment; LPS-1, LPS-0.5 and Saline and look for possible differences due to gender: Female 
and male. The within part of the analysis switches the variable tTime for the variable Treatment 
time on the second analysis. 






Video analyses allowed us to evaluate the behavior of mice in response to LPS treatments 
of both genders in C57BL/6 mice. The results are split into five groups: Weight, Acclimation-
OFT (we compared metrics as a function of both gender and treatment), Locomotion-Speed 
(cm/s), Locomotion-Distance (cm) and Behavior-DSCD. We were interested in quantifying 
observable changes in behavior due to a neuroinflammation caused by LPS injections. 
Weight 
 We measured the weights of the animals as a crude assessment of their health to see if 
they overcome relocation related stress, as published literature (Arndt, et al., 2009) has shown 
that sickness behavior is often first evidenced by weight loss (Vichaya, et al., 2019).  All subjects 
showed steady increments on their weight values after arrival as shown in Figure 5A. Subjects 
that received the injection with LPS treatment lost weight and Subjects that received the Saline 
solution only continued gaining weight. Figure 5B. Table 5 indicates that while before the 
injection, subjects gained weight (M = 3.3% , SD = 0.029), after the injection, they lost weight 
(M = - 4.7% , SD =0.064) 
The 3 x 2 Mixed ANOVA statistical analysis on weight change (Table. 2) revealed that 
there was significant change due to the Treatment, on both LPS conditions. Furthermore, post-
hoc analysis on the treatment effect on Gender revealed that both genders showed significant 




As seen on Figure 6A, before injection, they increased their weight at a rate of 3.3%, and 
as a group, they decreased their weight at a rate of 4.7% after the injection. It was noticeable that 
the mice that received the injection with the LPS treatment lost weight compared to the control 
or saline group. Indeed, while the saline group gained 3.32%, the LPS-0.5 lost 2.9% weight and 
the LPS-1 lost 2.4% see Figure 6B. The results of this post-hoc analysis is shown in Table 3. 
Acclimation 
We quantified the amount of time the mice stayed at the center of the arena as we defined 
the open field test (OFT) to be the ratio of the amount of time the animal spent in the center 
compared to the total time in the whole arena. It indicates the mouse is presenting a normal 
mouse behavior and that it did not change significantly due to the application of the injection,  
therefore it indicates fitness to continue with the subsequent behavioral testing. Normally a low 
OFT level is an indication of anxiety as they prefer to stay on the periphery (Seibenhener & 
Wooten, 2015).  
On average, there was no significant difference on the OFT values before (M = 0.13, SE 
= 0.02) and after (M = 0.11, SE = 0.02), t (23) = -1.48, p >.05, effect size r = 0.3. Wilcoxon test p 
= 0.19 > P(0.05). 
Locomotion 
 During both, the pretest (t1) and test (t2) sessions of the behavioral NOP, settings were 
set in place to collect the animals speed (cm/s) and distance (cm) ran during 10 minutes of video 
tracking. Both parameters will be used to evaluate the mouse’s ability to discriminate the object 
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when comparing data on t1 vs. t2 on the behavioral session only after the injection. Additionally, 
it serves to analyze t2 results by comparing the effects of the injection before and after 
application. For statistical analysis, tTime is the behavioral phase. It has two levels: t1 and t2, 
where t1 means familiar:familiar and t2 means familiar:novel. Whereas TreatmentTime is the 
time of the injection with two levels as well, before and after. 
DATA ANALYSIS ON THE “AFTER” CONDITION 
 This analysis will allow us to use data after the injection, to compare t1 and t2. 
Locomotion Speed 
 The Speed (cm/s) boxplot that shows the distribution of the speed (cm/s) data around the 
median, it is illustrated on Figure 9A.  Note that dots represent individual subjects and the center 
line is the median. The lowers side of the box represents 25% quartile values and the top portion 
of the box represents 75% quartile values. The QQ-plot for speed (Figure 9B) reveals an 
acceptable distribution of the speed data about by Gender and grouped by tTime, which is split 
into t1 and t2. Note that female subjects on the female group (lower quadrant) have dots out of 
the funnel. We confirmed that the speed data meets all statistical assumptions. First normal 
distribution, second homogeneity of variance and third extreme values. 
A 3 x 2 mixed ANOVA statistical analysis revealed one main effect. tTime was found 
significant F(1,18) = 4.43 p > 0.05. See Table 6.  The presence of the novel object (t2) resulted in 
mice running significantly slower (M = 2.61 cm/s, SD = 0.92) compared to t1 (M = 3.06 cm/s, 
SD = 1.32), see Table 7. We can conclude that they slowed down to explore the novel object. No 
gender differences and no differences due to Treatments were found to be significant.  
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Locomotion – Distance 
The distance (cm) boxplot that shows the distribution of the distance data around the 
median, it is illustrated on Figure 10A.  Note that dots represent individual subjects, and the 
center line is the median. The lowers side of the box represents 25% quartile values and the top 
portion of the box represents 75% quartile values. The QQ-plot for distance (Figure 10B) reveals 
an acceptable distribution of the speed data about by Gender and grouped by tTime, which is 
split into t1 and t2. Note that female subjects on the female group (lower quadrant) have dots out 
of the funnel. We confirmed that the distance data meets all statistical assumptions. First normal 
distribution, second homogeneity of variance and third extreme values. 
 
Similar to Speed (cm/s), distance is another parameter that will tell us if during the testing 
phase (t2), and the pretest phase (t1) the animals ran different distance on the arena due to the 
presence of the novel object. A 3 x 2 way mixed ANOVA statistical analysis reveals only one 
main effect was found to be significant, which is tTime F(1,18) = 5.19 p > 0.05. See Table 8.  
Independent of gender or condition all animals ran less during t2 when the novel object was 
present. Specifically, they ran on average 890 cm (SD = 377) during the 10 min of video 
recording on t1 when no novel object was presented and ran 746 cm (SD = 250) when they have 
the novel object. See Table 9, where we conclude that mice ran less in the arena due to the 
presence of the novel object, suggesting they are perceiving changes in the arena. 
Behavior test: Discriminatory Score of Cumulative Duration (DSCD) 
The discriminatory score of cumulative duration (DSCD) as we described on the Methods 
section will be the parameter that measures the mouse’s ability to discriminate the novel objects 
25 
 
from the familiar object due to its novelty as defined by its texture novelty (Wu, Ioffe, Iverson, & 
Boon, 2013). The factors were: Treatment with its three levels: LPS 1.0 mg/Kg, LPS 0.5 mg/Kg 
and Saline, the second factor was Gender with two levels Female and Male. Then the tTime with 
two levels t1 and t2, which indicates the pretest phase (t1) with two familiar objects and the 
testing phase (t2) with one familiar and one novel object. No discrimination is expected on t1 
because both objects are identical. The boxplots show the distribution of the DSCD data around 
the median, see Figure 11 A. The QQ plot for DSCD data also shows data within the funnel, see 
Figure 11B. The data passed all assumption’s analysis. 
A 3 x 2 mixed ANOVA statistical model performed on DSCD data shows that no main 
effect for Treatment, Gender, or tTime were found, and no interactions were found either. See 
Table 10. Table 11 shows the data of DSCD mean values for reference. 
DATA ANALYSIS ON THE “t2” CONDITION 
 This analysis will allow us to use data from the t2 condition to compare data from before 
to data after injection. We chose t2 because we expect to see discrimination due to the novelty of 
one of the objects. 
Locomotion Speed 
A 3 x 2 mixed ANOVA analysis applied for speed (cm/s) revealed no main effect on 
Treatment, Gender or Treatment time, however it revealed a Gender:TreatmentTime interaction 
to be significant (Table 12). Post-hoc analysis were performed to look for significance on Gender 
and Treatments. There were significant speed (cm/s) and distance (cm) differences between the 
genders and significant distance (cm) on both genders as well (See Table 13). For the 
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Gender:tTime interaction found on the Speed (cm/s) for “t2” data, then on the interaction on the 
Distance (cm) “t2” data ( Table 14) 
Initially we looked at the TreatmentTime effect on the Gender. During t2, Female 
subjects ran significantly faster after (M = 2.66 cm/s, SD = 1.03) than before (M = 2.05 cm/s, SD 
= 1.04) the injection. In contrast, Male subjects ran faster before (3.53 cm/s, SD = .49) than after 
the injection (M = 2.55 cm/s, SD = 1.03) as seen on Table 15. An illustration of mean’s 
comparison is shown in Figure 13. The bars indicate the population mean and the error bars 
represent the standard deviation. 
Locomotion Distance 
A 3 x 2 mixed ANOVA analysis applied for distance (cm) revealed no main effect on 
Treatment, Gender or Treatment time, however it revealed a Gender:TreatmentTime interaction 
to be significant (Table 17). Post-hoc analysis was performed to look for significance on Gender 
and Treatments. There were significant difference on distance (cm) on both genders as shown on 
Table 16.  
 Female subjects ran significant less distance (cm) before (M = 615 cm, SD = 311) than 
after (M = 762 cm, SD = 246). Opposed to males that ran significant less distance (cm) after (M 
= 730 cm, SD = 265) than before (M = 1045 cm, SD = 435) as Table 16 shows. Likewise, Figure 
14 compares mean distance values by gender and compares before and after. The error bars 
represent standard deviation. 
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Behavior test: Discriminatory Score of Cumulative Duration (DSCD) 
The statistical mixed ANOVA applied to DSCD data revealed no significant differences 
due to main effects of the factors: Gender, Treatment and TreatmentTime. There were no 




The main hypothesis was to test if there were changes in cognition due to 
microglia induced inflammation following the injection of LPS. Cognition is 
operationally defined as the ability of the mouse to discriminate a novel object of rough 
texture during the testing phase of our texture based novel object paradigm (NOP). Two 
doses of LPS were used: 0.5 mg LPS/Kg and 1.0 mg LPS/Kg. The injections included a 
control injection with Saline.  
Our study did not reveal changes on the discrimination score due to the Gender, 
the level of the Treatment, the Treatment time and no differences due to the tTime which 
is the pretest phase (t1) with two familiar objects compared to the testing phase (t2) 
familiar and novel object. 
We needed to know if the animals reacted to the presence of the novel object. We 
measured some observable changes on the locomotion patterns of the animals in regard to 
their speed and distance ran. We used data only after the injection to compare t1 vs. t2. 
There was statistical significance found on the tTime. It suggests that the subjects slowed 
down and ran less due to the presence of the novel object (t2) compared to the absence of 
the novel object (t1). It is similar to published findings, (Wu, Ioffe, Iverson, Boon, & 
Dyck, 2013), where it was shown that they reacted to novelty to explore, as seen in 
Figure 12A and Figure 12B. 
When we compared data during the testing phase (t2) to see if they reacted 
differently due to the application of the injection, we found an important interaction 
revealing that female and male subjects reacted totally differently. Indeed, while female 
subjects presented an accelerated locomotion based on speed (cm/s) and distance (cm), 
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male subjects presented the opposite reaction, and they slowed down and ran less, due to 
the injection. It is shown on Figure 13. 
LPS, which is an immune-stimulant from the outer membrane of Gram-negative 
bacteria (Zhao, et al., 2019) is used to induce an inflammatory response in mice (Sousa, 
et al., 2018). Based on the literature, microglia activation is part of the defense 
mechanism of the individuals. When an individual has a mild inflammation, microglia get 
activated to defend the individual from foreign invaders (Bellavance & Rivest, 2012). 
With this study, we tried to find cognitive implications deviating from normal due to the 
inflammatory response caused by LPS injections. In fact, after the injection of LPS the 
mouse displayed sickness signs. These signs are evidenced by reduction on their body 
mass Figure 5A. Comparing the subjects that received LPS to the Control that received 
Saline only as seen in Figure 5B, the control group continues to gain weight after the 
injection, as opposed to the LPS treated mice which lost weight. Additionally, the LPS 
injected animals presented a depressed-like look such as hunched back, tail drop and lack 
of desire to move around.  From the 36 hour to 72 hour post-LPS injection they showed 
signs of improvement. Our findings resemble those previously reported (Vichaya, et al., 
2019).  The testing phase (t2) of the behavioral paradigm took place in the third day to 
avoid interference of this sickness-like behavior to their task of discriminating the objects 
both by novelty and texture. 
LPS induced inflammation is a common mouse model used to study many 
disorders such as Alzheimer’s, Parkinson Disease, or even developmental related 
disorders such as Autism. Some used different doses to find an inflection point on 
cognitive decline (Vichaya, et al., 2019). Others on the other hand, compared a single 
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injection with repeated injections (Barter., Kumar, & Rani, 2020) and its impact on a 
chronic microglia activation effect (Chung, Welsh, Barres, & Stevens, 2015). Better yet, 
some researchers established differences between an IP injection and an intracerebral 
injection (Zhao, et al., 2019). Conversely, gathered evidence from recent research studies 
on this area shows that neuro-inflammation caused by LPS involves microglia activation 
(Kondo, Kohsaka, & Okabe, 2011) (Patterson, 2011). While an acute inflammation may 
trigger microglia activation that is beneficial in defending an individual from foreign 
invaders, chronic inflammation may present detrimental effects that lead to neuronal 
losses and the onset of cognitive impair and physiological damage (Zhao, et al., 2019). 
During the acclimation phase, the t-tests revealed no significant differences on the 
OFT score. Before and after the application of the treatment, the subjects preferred to stay 
on the open field a comparable amount of time. This assured readiness for the consequent 
phases of the paradigm. Therefore, it means two things: they do not present signs of 
anxiety, rather they adapt to the new housing conditions during the week prior to the 
experiment, but also that the injection did not affect their well-being. Since there were not 
significant differences of the OFT values, we assume the animals stay in the same 
condition they were before the injection. In other words, the OFT represented by the ratio 
of the time they spend in the center zone compared to the arena is comparable on both 
stages; “before” and “after” the injection.  
A 3x2 mixed factorial ANOVA revealed no significant differences on the DSCD 
due to the treatment conditions, nor due to the gender. To achieve a power of 90% with a 
significant level of 0.05 with a target difference of 15% between the mean, and 50% of 
chance level as well as an estimated standard deviation of 10%, the recommended sample 
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size was n=6 (Wu, Ioffe, Iverson, Boon, & Dyck, 2013). However, due to hardship 
caused by the current pandemic, my sample size was reduced to n=4. This decrease in 
sample size could influence my results. 
Automated behavioral devices were developed to collect data under controlled 
conditions in settings that resemble natural conditions. Behavioral studies require a high 
level of expertise to achieve reliable results (Romberg, et al., 2013). Some researchers 
use experimental procedures automatically resembling the subject’s habitat to avoid 
stress (Alboni, et al., 2017); others agree that the mouse’s behavior require ecological 
social settings to obtain reproducible results (Dere, Ronnenberg, Tampe, Arinrad, & 
Ehrenreich, 2018). The paradigm was tested with mice between two and six month olds 
(Wu, Ioffe, Iverson, Boon, & Dyck, 2013). We used two months old to comply with the 
age frame to successfully discriminate textures. 
Pharmacological manipulation of microglia using LPS is complex. One single 
injection of LPS has been found sufficient to produce a strong immune response (Sousa, 
et al., 2018).   Microglia activation is an effective defense mechanism that protect the 
individual from threats (Zhao, et al., 2019). High concentrations of LPS cause septic 
reactions (Ruiz, et al., 2016). Therefore, we needed to keep a low concentration, enough 
to cause a systemic inflammation but not enough to induce sepsis, we used 0.5 mg 
LPS/Kg of mouse’s weight and 1.0 mg LPS/Kg of mouse’s weight. Published literature 
found cognition was impacted within this concentration range (Zhao, et al., 2019). 
Perhaps a new experiment would consider using higher doses. The modified NOP for 
tactile discrimination test (Wu, Ioffe, Iverson, Boon, & Dyck, 2013) is promising. It 
offers insight into cognitive processes in a wide variety of manipulations. It could be used 
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to evaluate repetitive applications of treatments if spaced out enough to correct for 
learning effects. 
The neuron, widely known and accepted to be the protagonist of the marvelous 
nervous system cannot shine without the fine assistance of microglia. Precise 
communication between neurons through their synapses are influenced by microglia. The 
immune system responds to environmental clues and possesses the ability to affect 
neuronal synaptic processing through microglia activation. More research is needed to 
present evidence of how to intervene and correct mechanisms before serious damage to 
the neurons occurs. It would be an innovative approach that would offer better solutions 
to many neurological disorders while damage is still reversible. Sadly, nowadays many 
treatments used to control psychiatric conditions carry side effects that are almost as 
detrimental as the conditions. We need to offer better alternatives, perhaps targeting 






Sample size (n) by treatments and gender 
 Treatments 
Gender Saline LPS-1mg/Kg LPS-0.5 mg/Kg 
Female 4 4 4 
Male 4 4 4 




Weight Change Statistics Summary  3x 2 Mixed ANOVA (p<.05) 
Source  DFd/DFn F ges p 
Between 
 
     
Factor A (Treatment) 

















Within      
Factor C (TreatmentTime) 






















Note. * p < .05, ges = ɳ2 can be interpreted as effect size on an ANOVA model when comparison of two means. 
 
Table 3 
Treatment Time Effect on Treatments 
Treatment  DFd/DFn F ges p 
Saline  7/1 0.165 0.01 6.97e-01 
LPS-0.5  7/1 172.0 0.878 3.49e-06* 
LPS-1  7/1 30.8 0.775 8.57e-04* 






Treatment time Effect on Gender 
Gender t DFd/DFn F ges p 
Female  11/1 17.4 0.439 0.002* 
Male  11/1 14.3 0.423 0.423** 
Note. .  * = p < 0.05, ges = eta squared 
 
Table 5 
Weight Change, Mean and sd Values by Treatment Time 
TreatmentTime  n Mean SD 
before  24 0.033 0.029 
after  24 -0.047 0.064 
Note. n = sample size, SD = standard deviation 
     
 
Table 6     
Speed (cm/s) Statistics Summary 3 x 2 Mixed ANOVA (p<.05) 
 
Source  DFd/DFn F ges p 
Between 
 
     
Factor A (Treatment) 
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Factor C (tTime) 






















Note. * p < .05, ges = ɳ2 can be interpreted as effect size on an ANOVA model when comparison of two means. 
 
Table 7. 
Speed (cm/s) Mean values after injection 
tTime Variable n Mean (cm/s)  SD 
t1 Speed (cm/s) 24 3.06 1.32 
t2 Speed (cm/s) 24 2.61 0.92 






Distance (cm) Statistics Summary 3 x 2 Mixed ANOVA (p<.05) 
Source  DFd/DFn F ges p 
Between 
 
     
Factor A (Treatment) 

















Within      
Factor C (tTime) 






















Note. * p < .05, ges = ɳ2 can be interpreted as effect size on an ANOVA model when comparison of two means. 
 
Table 9  
Distance (cm) Mean and Standard deviation 
tTime Variable n Mean (cm)  SD 
t1 Distance (cm) 24 890 377 
t2 Distance (cm) 24 746 250 




Table 10   
DSCD – after injection Statistics Summary 3 x 2 Mixed ANOVA (p<.05) 
Source  DFd/DFn F ges p 
Between 
 
     
Factor A (Treatment) 
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Factor C (tTime) 




























Table 11    
DSCD mean values after injection 
tTime Variable n Mean  SD 
t1 DSCD 24 0.548 0.173 
t2 DSCD 24 0.608 0.187 
Note. n = sample size, SD = standard deviation 




Table 12    
Speed (cm/s) on “t2” - Statistics Summary 3 x 2 Mixed ANOVA (p<.05) 
Source  DFd/DFn F ges p 
Between 
 
     
Factor A (Treatment) 

















Within      
Factor C (TreatmentTime) 























Note. * p < .05, ges = ɳ2 can be interpreted as effect size on an ANOVA model when comparison of two means. 
 
 
Table 13   
Post-hoc on interaction found on Speed (cm/s) for “t2” 
  F(1,11) ges P < .05 
Female TreatmentTime 8.02 0.104 0.016* 
Male TreatmentTime 7.89 0.134 0.017* 






Table 14   
Post-hoc on interaction found on Distance (cm) for “t2” 
  F(1,11) ges P < .05 
Female TreatmentTime 6.07 0.070 0.031* 
Male TreatmentTime 10.10 0.173 0.009* 
Note. * p < .05, ges = ɳ2 can be interpreted as effect size on an ANOVA model when comparison of two means 
 
Table 15       
Speed (cm/s) mean values by gender before and after injection 
Gender TreatmentTime  n Mean (cm/s)  SD 
Female before  12 2.05 1.04 
Male before  12 3.53 1.49 
Female after  12 2.66 0.83 
Male after  12 2.55 1.03 
Note. SD = standard deviation 
 
 
Table 16      
Distance (cm) mean values by gender before and after injection 
Gender TreatmentTime  n Mean (cm)  SD 
Female before  12 615 311 
Male before  12 1045 435 
Female after  12 762 246 
Male after  12 730 265 


















Table 17    
Distance (cm) on “t2”- Statistics Summary 3 x 2 Mixed ANOVA (p<.05) 
Source  DFd/DFn F ges p 
Between 
 
     
Factor A (Treatment) 

















Within      
Factor C (TreatmentTime) 






















Note. * p < .05, ges = ɳ2 can be interpreted as effect size on an ANOVA model when comparison of two means. 
 
 
Table 18     
DSCD on t2 Statistics Summary 3 x 2 Mixed ANOVA (p<.05) 
Source  DFd/DFn F ges p 
Between 
 
     
Factor A (Treatment) 

















Within      
Factor C (TreatmentTime) 






























Figure 1.  Illustration of Neuroglia classification 
 
Figure 1. Illustrates Neuroglia classification (Verkhratsky, 2013) 
 
Figure 2. Microglia morphology 
 
Figure 2. Microglia morphology changes as a function of state. From left to right; 
resting, surveillant and active states (Soltys, et al., 2005). Modified illustration based 













Figure 3. Behavioral Paradigm. 3A. Before the injection. 3B. After the injection, 3C. Arena 











Figure 3. Acclimation phase consists of 10 minutes on the arena without objects. The pretest 
phase (t1) consists of 20 minutes on the arena with two familiar objects, followed by the test 




Figure 4. Timeline of the behavioral testing. 
 
Figure 4. Habituation means placement on the arena without objects for 20 minutes on day 
zero. The Novel object paradigm (NOP) was executed twice. Before the injection and two 
days after. Each NOP has three steps. First, Ten minutes acclimation with video recording 
without objects. Second, 20 minutes of video recording with two objects. This is called 
pretesting phase (t1) has two familiar objects and the testing phase (t2) has one familiar and 











 Figure 5.  Weigh mean values comparison (A) Subject’s weight until the day of the 
injection. (B) Weights before and after injection. The bars represent population means and 

















































Figure 6. Weight Change (%). 6A. Comparison before and after injection.  




Figure 6.  6A. while the group gain weight at a rate of 3.3% before the injection, after 
they lost 4.7%. An average of 6B While the Saline group remain gaining weight at a 
rate of 3.32%, both LPS treatments lost weight. The LPS-0.5mg/Kg lost 2.9% and the 




Figure 7. OFT as a function of TreatmentTime, bars represent Mean values, 
error bars (SD). 
 
Figure 7. No significant difference found before and after the injection on the 
OFT test, indicating that they have not changed their ability to explore the center 

















Figure 8A. Boxplots are based on the Median. Each dot represents a data point. Figure 8B. The 




Figure 9. (9A) Speed (cm/s) boxplot by Gender under both tTime conditions: t1 and t2. (B) 






Figure 9. 9A. Boxplots are based on the Median. Each dot represents a data point. Figure 9B. 




Figure 10. (10A) Distance (cm) boxplot by Gender under both tTime conditions: t1 and t2. 






Figure 10. 10A. Boxplots are based on the Median. Each dot represents a data point. 
Figure 10B. The QQ-plot shows the distribution of data. Attention to the lower 




Figure 11. (11A) Boxplot of the distribution for DSCD by Gender on both tTime conditions t1 






Figure 11. 11A. Boxplots are based on the Median. Figure 11B. The QQ-plot shows the 




Figure 12.  Comparison of Means. 12A. Speed (cm/s) Mean values after injection, 12B. 







Figure 12A. Speed (cm/s) mean values dropped due to the presence of the novel object. 
Figure 12B. Distance mean values also dropped due to the presence of the novel object. Bars 




Figure 13. Speed (cm) by gender before and after injection, bars represent mean values of 
the population and error bars (SD).  
 















Figure 14. Comparison of Means. Distance (cm/s) by Gender and by treatment   time. Bars 
represent mean and error bars(SD) 
 
Figure 14. Female subjects ran more distance (cm) after the injection. Male subjects ran less 
distance (cm) after the injection. 
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